ImmunoGenes, Kyowa Hakko Kirin deal

ImmunoGenes granted Kyowa Hakko a non-exclusive license to use ImmunoGenes' transgenic mouse technology to research, develop and commercialize therapeutic antibodies. Under the deal, Kyowa will be abl...